查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2153467

全球循環性腫瘤細胞市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Circulating Tumor Cells Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 241 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球循環性腫瘤細胞(CTC) 市場預計將從 2025 年的 153.1 億美元成長至 2034 年的 493.9 億美元，2026 年至 2034 年的複合年成長率 (CAGR) 為 13.9%。隨著研究人員和醫療保健專業人員將循環性腫瘤細胞作為癌症進展和治療反應的潛在資訊來源進行研究，該市場的重要性日益凸顯。循環性腫瘤細胞是指從腫瘤脫落並進入血液的癌細胞。在某些研究和臨床環境中，無需重複組織取樣即可檢測和分析這些細胞，從而深入了解腫瘤特徵。人們對液態生物檢體、精準腫瘤學和微創監測的興趣日益濃厚，推動了分離和識別這些稀有細胞的技術發展。然而，它們的臨床效用因癌症類型、檢測方法和應用場景而異。

市場成長主要得益於癌症研究的進展、細胞分離技術的改進以及對液態生物檢體平台投資的增加。研究人員正利用物理特性、細胞表面標誌物、影像和分子分析等方法，從大量的血球中辨識循環性腫瘤細胞。診斷技術公司和研究機構正在探索其在治療監測、預後評估和轉移性疾病研究中的應用。微流體技術、自動化影像分析和單細胞分析的進步也為更精細的表徵提供了支持。生物技術公司與腫瘤研究中心之間的合作正在推動技術開發和臨床評估的進步。

該市場的未來前景取決於更強力的臨床檢驗、更高的檢測靈敏度以及標準化檢測方法的開發。單細胞定序和分子譜分析技術的進步有望提供關於腫瘤異質性和潛在治療抗藥性的更詳細資訊。與其他液態生物檢體技術的整合將有助於研究人員更全面地了解癌症進展。然而，細胞計數低、腫瘤間差異、技術複雜性以及對可重複結果的需求仍然是重大挑戰。為了更廣泛地應用，需要有明確的證據證明，在特定情況下，循環性腫瘤細胞分析能夠改善臨床決策和病患管理。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球循環性腫瘤細胞市場：依產品分類

  • 市場分析、洞察與預測
  • 試劑盒和試劑
  • 採血管
  • 醫療設備

第5章 全球循環性腫瘤細胞市場：依技術分類

  • 市場分析、洞察與預測
  • CTC檢測與濃縮方法
  • 直接檢測循環腫瘤細胞
  • CTC分析

第6章 全球循環性腫瘤細胞市場：依應用領域分類

  • 市場分析、洞察與預測
  • 研究、臨床
  • 藥物和療法的研發

第7章 全球循環性腫瘤細胞市場：依檢體類型分類

  • 市場分析、洞察與預測
  • 血
  • 骨髓
  • 其他體液

第8章 全球循環性腫瘤細胞市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 診斷中心
  • 研究和學術機構

第9章 全球循環性腫瘤細胞市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Menarini Silicon Biosystems
    • Bio-Rad Laboratories
    • QIAGEN
    • Thermo Fisher Scientific
    • Roche
    • Epic Sciences
    • RareCyte
    • Biocept
    • ScreenCell
    • Celsee
    • ANGLE
    • Ikonisys
    • CytoTrack
    • ApoCell
    • Canopus Bioscience
    • Creatv MicroTech
    • AdnaGen
    • Sysmex
    • STEMCELL Technologies
    • Miltenyi Biotec
簡介目錄
Product Code: VMR11212629

The global circulating tumor cells market size is expected to reach USD 49.39 Billion in 2034 from USD 15.31 Billion in 2025, growing at a CAGR of 13.9% during 2026-2034.This market is gaining importance as researchers and healthcare professionals investigate circulating tumor cells as potential sources of information about cancer progression and treatment response. Circulating tumor cells are cancer cells that detach from tumors and enter the bloodstream. Their detection and analysis may provide insights into tumor characteristics without requiring repeated tissue sampling in certain research or clinical settings. Growing interest in liquid biopsy, precision oncology, and minimally invasive monitoring is encouraging the development of technologies that isolate and characterize these rare cells. However, their clinical usefulness depends on the cancer type, testing method, and intended application.

Market growth is driven by advances in cancer research, improvements in cell isolation technologies, and increasing investment in liquid biopsy platforms. Researchers are developing methods that use physical properties, cell-surface markers, imaging, and molecular analysis to identify circulating tumor cells among large numbers of blood cells. Diagnostic technology companies and research institutions are exploring applications in treatment monitoring, prognosis assessment, and investigation of metastatic disease. Improvements in microfluidics, automated imaging, and single-cell analysis are also supporting more detailed characterization. Collaborations between biotechnology companies and oncology research centers are helping advance technical development and clinical evaluation.

The future prospects of this market will depend on stronger clinical validation, improved detection sensitivity, and the development of standardized testing methods. Advances in single-cell sequencing and molecular profiling could provide more detailed information about tumor heterogeneity and potential treatment resistance. Integration with other liquid biopsy approaches may help researchers build a more comprehensive picture of cancer progression. However, low cell counts, variation between tumors, technical complexity, and the need for reproducible results remain significant challenges. Broader adoption will require clear evidence that circulating tumor cell analysis improves clinical decisions or patient management in defined settings.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Kits & Reagents
  • Blood Collection Tubes
  • Devices

By Technology

  • CTC Detection & Enrichment Methods
  • CTC Direct Detection
  • CTC Analysis

By Application

  • Research, Clinical
  • Drug/Therapy Development

By Specimen

  • Blood
  • Bone Marrow
  • Other Body Fluids

By End User

  • Hospital and Clinics
  • Diagnostic Centers
  • Research and Academic Institutes

COMPANIES PROFILED

  • Menarini Silicon Biosystems, Bio-Rad Laboratories, QIAGEN, Thermo Fisher Scientific, Roche, Epic Sciences, RareCyte, Biocept, ScreenCell, Celsee, ANGLE, Ikonisys, CytoTrack, ApoCell, Canopus Bioscience, Creatv MicroTech, AdnaGen, Sysmex, STEMCELL Technologies, Miltenyi Biotec

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CIRCULATING TUMOR CELLS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Blood Collection Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CIRCULATING TUMOR CELLS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Technology
  • 5.2. CTC Detection & Enrichment Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. CTC Direct Detection Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. CTC Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CIRCULATING TUMOR CELLS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Research, Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Drug/Therapy Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CIRCULATING TUMOR CELLS MARKET: BY SPECIMEN 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Specimen
  • 7.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Bone Marrow Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Other Body Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CIRCULATING TUMOR CELLS MARKET: BY END USER 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End User
  • 8.2. Hospital and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL CIRCULATING TUMOR CELLS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Technology
    • 9.2.3 By Application
    • 9.2.4 By Specimen
    • 9.2.5 By End User
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Technology
    • 9.3.3 By Application
    • 9.3.4 By Specimen
    • 9.3.5 By End User
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Spain
    • 9.3.11 Russia
    • 9.3.12 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Technology
    • 9.4.3 By Application
    • 9.4.4 By Specimen
    • 9.4.5 By End User
    • 9.4.6 China
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 India
    • 9.4.10 Australia
    • 9.4.11 South East Asia
    • 9.4.12 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Technology
    • 9.5.3 By Application
    • 9.5.4 By Specimen
    • 9.5.5 By End User
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Technology
    • 9.6.3 By Application
    • 9.6.4 By Specimen
    • 9.6.5 By End User
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL CIRCULATING TUMOR CELLS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Menarini Silicon Biosystems
    • 11.2.2 Bio-Rad Laboratories
    • 11.2.3 QIAGEN
    • 11.2.4 Thermo Fisher Scientific
    • 11.2.5 Roche
    • 11.2.6 Epic Sciences
    • 11.2.7 RareCyte
    • 11.2.8 Biocept
    • 11.2.9 ScreenCell
    • 11.2.10 Celsee
    • 11.2.11 ANGLE
    • 11.2.12 Ikonisys
    • 11.2.13 CytoTrack
    • 11.2.14 ApoCell
    • 11.2.15 Canopus Bioscience
    • 11.2.16 Creatv MicroTech
    • 11.2.17 AdnaGen
    • 11.2.18 Sysmex
    • 11.2.19 STEMCELL Technologies
    • 11.2.20 Miltenyi Biotec